Dipòsit Digital de Documents de la UAB
Publication
Artículo científico (JournalArticle)
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
Background: The present work evaluates the association between circulating concentrations of Trimethylamine-N-oxide (TMAO), gamma butyrobetaine (γBB), and trimetyllisine (TML) in controls and patients with venous thromboembolism (VTE) with coagulation parameters. Methods: The study involved 54 VTE patients and 57 controls. Platelet function, platelet hyperreactivity, platelet adhesiveness, thrombosis-associated parameters, and thrombin generation parameters were studied. Plasma TMAO, γBB, and TML determination was performed using an ultra-high-performance liquid chromatography system coupled with mass spectrometry. Results: No differences were found for TMAO, γBB, or TML concentrations between controls and VTE patients. In thrombin generation tests, TMAO, γBB, and TML showed a positive correlation with lag time and time to peak. TMAO, γBB, and TML negatively correlated with peak height. No significant differences were observed regarding TMAO, γBB, and TML concentrations between the two blood withdrawals, nor when the control and VTE patients were analyzed separately. No correlation was observed between these gut metabolites and platelet function parameters. Conclusions: No differences were found regarding TMAO, γBB, and TML concentrations between the control and VTE groups. Some correlations were found; however, they were mild or went in the opposite direction of what would be expected if TMAO and its derivatives were related to VTE risk.
Project:
Agencia Estatal de Investigación RYC-201722879
,
Instituto de Salud Carlos III PI18-00164
,
Instituto de Salud Carlos III PI21-00140
,
Ministerio de Economía y Competitividad PI12/00612
,
Ministerio de Economía y Competitividad PI15/00269
,
Instituto de Salud Carlos III PI18/00434
,
Instituto de Salud Carlos III PI19-00136
,
Instituto de Salud Carlos III CM20/00033
,
Instituto de Salud Carlos III CPII18/00004
,
Ministerio de Ciencia e Innovación RED2018-102799-T